| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders |
| 08/26/2004 | US20040166099 Molecules preferentially associated with effector T cells and methods of their use |
| 08/26/2004 | US20040166098 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 08/26/2004 | US20040166097 Therapy for bone disease or lung defect |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | US20040166091 Materials and methods for treating disorders of the ear |
| 08/26/2004 | US20040166061 drug screening for antidiabetic or antiobesity agents by determining whether a test compound activates expression of the human transcription factor gene FKHL14/FOXC2, winged helix protein; using mouse model of obesity to test the potential drug |
| 08/26/2004 | CA2516344A1 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | CA2515368A1 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515083A1 Topical delivery of cosmetic agents |
| 08/26/2004 | CA2514912A1 Rnai targeting of viruses |
| 08/26/2004 | CA2512934A1 Short immunomodulatory oligonucleotides |
| 08/25/2004 | EP1449925A1 Method of diagnosis of type 2 diabetes |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449542A1 Genetic remedies for neurodegenerative diseases |
| 08/25/2004 | EP1449541A1 Compositions inhibiting rejection in organ transplantation and method of using the same |
| 08/25/2004 | EP1448782A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
| 08/25/2004 | EP1448771A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448770A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448599A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 08/25/2004 | EP1448598A2 Novel immunogenic mimetics of multimer proteins |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448586A2 Therapeutic methods for nucleic acid delivery vehicles |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448223A2 Thymosin augmentation of genetic immunization |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448152A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 08/25/2004 | EP1448089A2 Devices and methods for the restoration of a spinal disc |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1190257B1 Early detection of flaviviruses using the ns1 glycoprotein |
| 08/25/2004 | EP0983391B1 Method for diagnosing alzheimer disease |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | CN1524128A DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 08/25/2004 | CN1524125A 化合物 Compound |
| 08/25/2004 | CN1524122A Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 08/25/2004 | CN1524090A Modified insulin with reduced immunogenicity |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1523999A DNA expression vectors and methods of use |
| 08/25/2004 | CN1523113A Construction of hepatitis B virus siRNA expression vector and its application in antivirus treatment |
| 08/25/2004 | CN1523112A Tetracycline-regulated transcriptional modulators |
| 08/25/2004 | CN1523111A Secretion expressing type myocardium gene treating plasmid vector |
| 08/25/2004 | CN1522761A Composite hepatitis B vaccine for treatment and its preparation method |
| 08/25/2004 | CN1522760A Bivalent gene engineering vaccine of fowl infectious bursal disease and pasteurellosis |
| 08/25/2004 | CN1163614C Expression vector of human and mammal cell |
| 08/25/2004 | CN1163603C Enhanced internal translation factor of eukaryotic cell and its use |
| 08/25/2004 | CN1163602C Fusion protein of tubercle bacillus antigen, and its use |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/24/2004 | US6780986 Human zinc finger protein rip60 ; isolated nucleic acid molecules, expression vectors containing these molecules and host cells transfected with the molecules |
| 08/24/2004 | US6780983 Polypeptide having water channel activity and DNA sequence |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
| 08/24/2004 | US6780644 For catalyzing site-specific resolution (deletion) of dna sequences when the two target sequences in a plasmid (extrachromosomal target) introduced in the cell by transfection |
| 08/24/2004 | US6780642 Association of SIM2 with cancer |
| 08/24/2004 | US6780641 Genetically modified human embryonic cells using a viral vector encoding an oncogene, can express active cytokines, chemokines, and other cytotoxic and neurotoxic substances; used for screening of compounds for diseases |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780610 Identification of a smooth muscle cell (SMC) specific smooth muscle heavy chain (SM-MHC) promoter/enhancer |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780409 Glutamic acid decarboxylase (GAD) based delivery system |
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/19/2004 | WO2004070041A1 Vectors for expression of toxins |
| 08/19/2004 | WO2004070018A2 Vegf-b and pdgf modulation of stem cells |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070008A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | WO2004070002A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069326A2 Light probe for ultraviolet light activated gene transduction |
| 08/19/2004 | WO2004069279A1 Composition for intracellular transport of biological particles or macromolecules |
| 08/19/2004 | WO2004069269A1 Method for making a cell more susceptible for a compound by expressing the protein, on which said compound acts, in said cell |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069207A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069206A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069194A2 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 08/19/2004 | WO2004058323A3 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004050829A3 Recombinant double-stranded rna phage, and use of the same |
| 08/19/2004 | WO2004050702A3 Novel ifngamma-like polypeptides |
| 08/19/2004 | WO2004047770A3 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 08/19/2004 | WO2004029075A3 Peptide nucleic acids having improved uptake and tissue distribution |
| 08/19/2004 | WO2004017909A3 Methods of reducing ischemic injury |
| 08/19/2004 | WO2004016805A9 Immunostimulatory nucleic acids |
| 08/19/2004 | WO2004016215A3 Use of antisense oligonucleotides to inhibit the expression of akt-1 |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003037260A3 Methods and compositions for treating parkinson's disease |
| 08/19/2004 | US20040163147 Nucleic acid sequences comprising pericentric heterochromatic region of a chromosome and nucleotide sequences which confer disease resistance to plants for use in generation of satellite DNA based artificial chromosomes |
| 08/19/2004 | US20040163140 Biological material |